Skip to content
ES
MARKETS / NASDAQ / ENSG
NASDAQ · SERVICES-SKILLED NURSING CARE FACILITIES · LARGE CAP

Ensign Group, Inc. ENSG

17 fiscal years on record · USD · FY2025 reported · SEC filings only
10 YEARS OF DIVIDEND GROWTH
$5.0B
▲ 18.8% YoY
$344.0M
▲ 15.4% YoY
In brief

What this company does

The Ensign Group, Inc., through its independent subsidiaries, provides skilled nursing, senior living and rehabilitative services, as well as other ancillary businesses including mobile diagnostics and medical transportation, in 17 states. For the year ended December 31, 2025, it generated approximately 95.6% of its revenue from its skilled nursing facilities. As of December 31, 2025, it offered skilled nursing, senior living and rehabilitative care services through 373 skilled nursing and senior living facilities. It has two reportable segments: skilled services, which includes the operation of skilled nursing facilities and rehabilitation therapy services, and Standard Bearer, which is comprised of select properties owned through its captive REIT and leased to skilled nursing and senior living operations, including its own independent subsidiaries and third-party operators. As of December 31, 2025, its skilled nursing companies provided skilled nursing care at 357 operations, with 37,911 operational beds. As of December 31, 2025, its real estate portfolio within Standard Bearer comprised 152 real estate properties. The Ensign Group, Inc. was founded in 1999.

Written from the business description in ENSIGN GROUP, INC's annual report to the U.S. Securities and Exchange Commission, filed 4 February 2026. Every sentence was checked against that document before publication.

Growth
USD 5.0B
Revenue, FY2025 · full 17-year series below
Revenue $B Net income $B
FY2025 · Revenue 5.0 · Net income 0.3
2B4B200920112013201520172019202120232025
Compound annual growth
+18.5%
+16.1%
+14.1%
+14.6%
+15.3%
+15.1%
+20.0%
+15.3%
+13.9%
+13.8%
+18.6%
+4.3%
+4.5%
+5.2%
−21.1%
−9.1%
+6.8%
+8.7%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at +16.1% a year over five years — but profit grew slower: net income at +15.1%, earnings per share at +13.8%.

The share count rose from 0.05B to 0.06B over the period.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability
7 cents
of every revenue dollar became profit
Operating margin Net margin
FY2025 · Operating 8.5% · Net 6.8%
5%10%200920112013201520172019202120232025
ROE
FY2025 · ROE 16.9%
10%20%200920112013201520172019202120232025
Gross margin20.1%
Operating margin8.5%
Net margin6.8%
Return on assets6.8%
EBITDAUSD 529.6M

Each USD of equity produced 17 cents of profit this year.

Cash & shareholders
USD 14.4M
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2019 · FCF 120.7
80M-10M-20M200920112013201520172019202120232025
Net buybacks $M Dividends $M
FY2025 · Dividends 14.4 · Net buybacks -9.0
20M-40M-80MDividendsNet buybacks200920112013201520172019202120232025
Dividends paidUSD 14.4M
Net buybacksUSD -9.0M
Share of profit4.2%
Consecutive raises10 years (since the 2015 share-count change)

USD 14.4M in dividends — 4% of the year's profit went back to shareholders.

Total assetsUSD 5.5B
EquityUSD 2.2B
CashUSD 503.9M
Gross debtUSD 141.8M
Net debtUSD -362.1M
Current ratio1.42×

The company holds more cash than debt.

The 17-year record
17 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative
Metric 20252024202320222021202020192018201720162015201420132012201120102009
Revenue $B5.04.23.73.02.62.42.01.81.61.71.31.00.90.80.80.60.5
Operating income $B0.40.40.30.30.30.20.10.10.00.10.10.10.10.10.10.10.1
EBITDA $B0.50.40.30.40.30.30.20.10.10.10.10.10.10.10.10.10.1
Income tax $B0.10.10.10.10.10.00.00.00.00.00.00.00.00.00.00.00.0
Net income $B0.30.30.20.20.20.20.10.10.00.00.10.00.00.00.00.00.0
Free cash flow $B······0.10.20.00.0−0.00.00.00.00.00.00.0
EPS, diluted $5.845.123.653.953.423.061.971.700.770.961.060.780.541.852.211.921.55
Dividend / sh $0.250.240.230.220.210.200.190.180.170.160.150.140.130.250.23−4268000.00−3813000.00
Payout %456566910221614181816101011
ROE %16.917.915.319.821.223.217.817.18.511.316.211.77.013.418.919.517.3
Shares out B0.060.060.060.060.060.050.050.050.050.050.050.020.020.020.020.02·

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Provenance
Company facts, as filed
How we verify · 0 failures in 64 reconciliationsAUDITED

Reconciled in 17 of 19 fiscal years. 19 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityServices-Skilled Nursing Care Facilities
Listed onNASDAQ
Incorporated innot stated in the filings
Fiscal year endsDecember 31
Data on record since2009

Share this section

Download image